US5604126AExpiredUtility

Murine hybridoma 4A11 and diagnostic antibody produced thereby

42
Assignee: UNIV NORTHWESTERNPriority: Apr 6, 1992Filed: May 26, 1995Granted: Feb 18, 1997
Est. expiryApr 6, 2012(expired)· nominal 20-yr term from priority
Inventors:Alisa E. Koch
C07K 16/28
42
PatentIndex Score
6
Cited by
42
References
2
Claims

Abstract

Hybridoma 4A11 produces a murine IgM monoclonal antibody specifically against endothelial cells in diseased tissues such as rheumatoid and osteoarthritis synovial tissues, and psoriatic skin. The 4A11 antibody has possible clinical utility for detection of human endothelial cells mainly in inflamed and malignant disease states.

Claims

exact text as granted — not AI-modified
I claim: 
     
       1. The hybridoma cell line deposited under ATCC Accession No. HB11274. 
     
     
       2. The monoclonal antibody produced by the hybridoma cell line deposited under ATCC Accession No. HB 11274.

Join the waitlist — get patent alerts

Track US5604126A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.